Cue Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Cue Biopharma, Inc. (CUE) had Lessee, Operating Lease, Liability, to be Paid, Year One of $921.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-14
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $921.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.37M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.23M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $630.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $921.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.37M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $2.23M 10-K · filed 2026-03-16 |
| 2025-09-30 | $630.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.26M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $2.68M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $3.54M 10-K · filed 2025-03-31 |
| 2024-09-30 | $803.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.67M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.53M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $3.37K 10-K · filed 2024-03-28 |
| 2023-09-30 | $835.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $1.67M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.49M 10-Q · filed 2023-05-09 |
| 2020-09-30 | $5.08M 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |